- Offerings
- Tools & Platforms
Tools & Calculators
- Open API
- Calculators
- SIP Calculator
- CAGR Calculator
- Compound Interest Calculator
- FD Calculator
- RD Calculator
- EPF Calculator
- Retirement Calculator
- HDFC SIP Calculator
- Mutual Fund Return Calculator
- Lumpsum Calculator
- Step Up SIP Calculator
- ETF SIP Calculator
- Brokerage Calculator
- Equity Margin Calculator
- SWP Calculator
- EMI Calculator
- MTF Calculator
- Markets
Stocks
F&O
Mutual Funds
- More
Scheme Information
Nippon India Pharma IDCW-P
as of 25 Apr 2026, 15:38 PM
SIP Calculator
Invested Amount
₹6,00,000
Est. Return
₹5,61,695
Total Value
₹11,61,695
Scheme Ratings
rated by Value Research
Scheme Riskometer
Your principal will be at Very High Risk
Investment Returns
Absolute Returns
CAGR
Company Holdings
Company Name | Sector | Instrument | Assets |
|---|---|---|---|
| Sun Pharmaceuticals Industries Ltd | Healthcare | E | 13.92% |
| Lupin Ltd | Healthcare | E | 8.45% |
| Divi's Laboratories Ltd | Healthcare | E | 6.41% |
| Dr Reddy's Laboratories Ltd | Healthcare | E | 5.96% |
| Cipla Ltd | Healthcare | E | 5.42% |
| Apollo Hospitals Enterprise Ltd | Healthcare | E | 5.15% |
| Medplus Health Services Ltd | Healthcare | E | 3.86% |
| Ajanta Pharma Ltd | Healthcare | E | 3.36% |
| Max Healthcare Institute Ltd Ordinary Shares | Healthcare | E | 3.24% |
| Vijaya Diagnostic Centre Ltd | Healthcare | E | 3.15% |
| Sai Life Sciences Ltd | Healthcare | E | 3.15% |
| Mankind Pharma Ltd | Healthcare | E | 2.87% |
| Aurobindo Pharma Ltd | Healthcare | E | 2.81% |
| Ipca Laboratories Ltd | Healthcare | E | 2.77% |
| GlaxoSmithKline Pharmaceuticals Ltd | Healthcare | E | 2.64% |
| Abbott India Ltd | Healthcare | E | 2.43% |
| Alkem Laboratories Ltd | Healthcare | E | 2.17% |
| J.B. Chemicals & Pharmaceuticals Ltd | Healthcare | E | 2.09% |
| Dr. Lal PathLabs Ltd | Healthcare | E | 2.02% |
| Thyrocare Technologies Ltd | Healthcare | E | 1.94% |
| Pfizer Ltd | Healthcare | E | 1.90% |
| Gland Pharma Ltd | Healthcare | E | 1.72% |
| Narayana Hrudayalaya Ltd | Healthcare | E | 1.67% |
| Emcure Pharmaceuticals Ltd | Healthcare | E | 1.51% |
| Sanofi Consumer Healthcare India Ltd | Healthcare | E | 1.16% |
| Suraksha Diagnostic Ltd | Healthcare | E | 1.12% |
| Fortis Healthcare Ltd | Healthcare | E | 1.11% |
| Sanofi India Ltd | Healthcare | E | 0.94% |
| Syngene International Ltd | Healthcare | E | 0.93% |
| Akums Drugs and Pharmaceuticals Ltd | Healthcare | E | 0.89% |
| Anthem Biosciences Ltd | Healthcare | E | 0.88% |
| Biocon Ltd | Healthcare | E | 0.67% |
| AstraZeneca Pharma India Ltd | Healthcare | E | 0.62% |
| Indoco Remedies Ltd | Healthcare | E | 0.38% |
| Concord Biotech Ltd | Healthcare | E | 0.14% |
| Triparty Repo | - | CR | 0.86% |
| Net Current Assets | - | C | 0.33% |
| Cash Margin - Ccil | - | CR | 0.00542% |
| Cash | - | C | 0% |
Sector Holding Analysis
Equity / Debt / Cash Split
Equity
99.46%
Cash
0.54%
Equity sector allocation
Healthcare
99.46%
Others
0.54%
Fund House Contact Details
Asset Management Company
Funds in this Category
Nippon India Taiwan Equity Reg Gr
Equity
Min. Investment
₹500
Category Returns
32.40%
60.73%
3Y Returns
+60.73%
Mirae Asset NYSE FANG+ ETF FoF Reg Gr
Equity
Min. Investment
₹5000
Category Returns
32.40%
60.73%
3Y Returns
+48.34%
DSP Wld Gld Mng Ovrs Eq Omni FoF Gr
Equity
Min. Investment
₹100
Category Returns
32.40%
60.73%
3Y Returns
+45.98%
About Nippon India Pharma IDCW-P
Investment Objective of the Scheme
Key Features of The Fund
5-year return
+13.92%
Fund Manager
Sailesh Raj Bhan
Risk Profile
Very High Risk
Expense Ratio
1.82%
Fund Size
₹7898.24 Cr
FAQ's
What has been the returns generated by Nippon India Pharma IDCW-P over different time periods?
What is the expense ratio of Nippon India Pharma IDCW-P?
What is the AUM (Assets Under Management) of Nippon India Pharma IDCW-P?
What are the top stock holdings of Nippon India Pharma IDCW-P?
The Nippon India Pharma IDCW-P has invested the majority of its money in the stocks of the following companies:
| Company | Percentage of Portfolio |
|---|---|
| Sun Pharmaceuticals Industries Ltd | 13.92% |
| Lupin Ltd | 8.45% |
| Divi's Laboratories Ltd | 6.41% |
| Dr Reddy's Laboratories Ltd | 5.96% |
| Cipla Ltd | 5.42% |
| Apollo Hospitals Enterprise Ltd | 5.15% |
| Medplus Health Services Ltd | 3.86% |
| Ajanta Pharma Ltd | 3.36% |
| Max Healthcare Institute Ltd Ordinary Shares | 3.24% |
| Vijaya Diagnostic Centre Ltd | 3.15% |
| Sai Life Sciences Ltd | 3.15% |
| Mankind Pharma Ltd | 2.87% |
| Aurobindo Pharma Ltd | 2.81% |
| Ipca Laboratories Ltd | 2.77% |
| GlaxoSmithKline Pharmaceuticals Ltd | 2.64% |
| Abbott India Ltd | 2.43% |
| Alkem Laboratories Ltd | 2.17% |
| J.B. Chemicals & Pharmaceuticals Ltd | 2.09% |
| Dr. Lal PathLabs Ltd | 2.02% |
| Thyrocare Technologies Ltd | 1.94% |
| Pfizer Ltd | 1.90% |
| Gland Pharma Ltd | 1.72% |
| Narayana Hrudayalaya Ltd | 1.67% |
| Emcure Pharmaceuticals Ltd | 1.51% |
| Sanofi Consumer Healthcare India Ltd | 1.16% |
| Suraksha Diagnostic Ltd | 1.12% |
| Fortis Healthcare Ltd | 1.11% |
| Sanofi India Ltd | 0.94% |
| Syngene International Ltd | 0.93% |
| Akums Drugs and Pharmaceuticals Ltd | 0.89% |
| Anthem Biosciences Ltd | 0.88% |
| Biocon Ltd | 0.67% |
| AstraZeneca Pharma India Ltd | 0.62% |
| Indoco Remedies Ltd | 0.38% |
| Concord Biotech Ltd | 0.14% |
| Triparty Repo | 0.86% |
| Net Current Assets | 0.33% |
| Cash Margin - Ccil | 0.01% |
| Cash | 0.00% |
In which sectors has Nippon India Pharma IDCW-P invested in?
The Nippon India Pharma IDCW-P has invested the majority of its money in the stocks of the following sectors -
| Company | Percentage of Portfolio |
|---|---|
| Basic Materials | - |
| Communication Services | - |
| Consumer Cyclical | - |
| Consumer Defensive | - |
| Energy | - |
| Financial Services | - |
| Healthcare | 99.46% |
| Industrials | - |
| Real Estate | - |
| Technology | - |
| Utilities | - |
What is the risk level of Nippon India Pharma IDCW-P?
Who are the fund managers of Nippon India Pharma IDCW-P?
Is there a minimum SIP amount to invest in Nippon India Pharma IDCW-P?
Can I invest in Nippon India Pharma IDCW-P both in SIP and lump sum?
How to invest in Nippon India Pharma IDCW-P?
Investing in mutual funds is easy on HDFC SKY.
Follow these simple steps to invest in Nippon India Pharma IDCW-P:
- On HDFC SKY open your demat account if you don't have one.
- Check the performance of Nippon India Pharma IDCW-P.
- Choose between SIP or Lumpsum and start your mutual fund investment journey on HDFC Sky.
Is there any exit load charges of Nippon India Pharma IDCW-P?
The exit load of Nippon India Pharma IDCW-P is as follows:
Exit load of 1.0%, if redeemed within 1 year
.What is the process to redeem my investment in HDFC SKY?
The following are the Steps to Redeem mutual funds on HDFC SKY:
1. Go to Mutual Funds > My Investments/Portfolio.
2. Select the fund and tap Redeem/Sell.
3. Choose Full, Units, or Amount.
4. Review NAV, units, and exit load.
5. Confirm. Amount (Units × NAV) is credited to the registered bank in T+1–T+3 days. ELSS has a 3-year lock-in.
By signing up I certify terms, conditions & privacy policy